Effect of Vibration and Cold Application on Chest Tube Removal Pain After CABG
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jan 11, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using vibration and cold treatments can help reduce pain and anxiety when removing chest tubes after heart surgery, specifically coronary artery bypass graft (CABG) surgery. Chest tubes are often placed during surgery to help drain air, blood, or fluid from around the heart and lungs. While these tubes are important for recovery, their removal can be quite painful for patients. The goal of this research is to find out if non-drug methods like vibration and cold can provide effective relief from this pain.
To participate in the study, patients need to be between the ages of 40 and 65, must be having a chest tube removed for the first time, and should be alert and able to cooperate. They will be closely monitored to assess their pain and anxiety levels during the chest tube removal process. The trial will take place in a hospital in Istanbul from January 2024 to January 2025, and participation will require consent after being fully informed about the study. This trial is important because it could lead to better pain management techniques that do not rely solely on medications, which can sometimes have side effects.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A chest tube was placed for the first time
- • ASA (American Society of Anesthesiology) classification I and II
- • Those between the ages of 40-65
- • Conscious, oriented and cooperative
- • Patients who agree to participate in the research verbally and in writing after being informed about the research
- Exclusion Criteria:
- • Having a chest tube for more than 72 hours
- • More than one chest tube entry and removed at the same time
- • A chest tube was removed from the area close to the sternotomy line
- • Having compromised skin integrity (burn, laceration, scar, inflammation, infection, erythema) around the chest tube and in the application area
- • Having a history of thoracotomy
- • Those who are intubated
- • Those with cold urticaria
- • Under the influence of anesthesia or analgesia
- • Complications developed during or after surgical intervention
- • Those who do not speak Turkish and have hearing and vision problems
- • Having a diagnosed psychiatric disease or mental problem
- • Having a body mass index ≥30
- • Patients who participated in another clinical trial during the same period
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Trial Officials
Oyku Kara, MSc
Principal Investigator
Istanbul University - Cerrahpasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported